Published Paper Details:

Iron deficiency anaemia in pregnancy is common in India, and also associated with an increased risk of premature birth and low birth weight, preeclampsia, placental abruption, and increased peripartum blood loss as well as cardiac failure and related death. Health care providers working in periphery do not administer iron sucrose due to many constraints such as technique of administration, serum iron studies are not available, etc. We therefore studied the efficacy and safety of intravenous iron sucrose for the treatment of iron deficiency anaemia in pregnant & postpartum women with moderate anaemia at our tertiary center, with hemoglobin level measurements at baseline & follow up. Present study was a prospective, interventional study conducted in pregnant women & postpartum women with moderate anemia received intravenous iron sucrose. Out of 200 patients, 124 (62%) patients were antenatal & 76 (38 %) were postpartum. After intravenous iron sucrose in antenatal women & postpartum women, a significant rise was noted at 2 week, 4 week & 6 weeks. Iron deficiency anaemia in antenatal & postpartum women treated with intravenous iron sucrose had effective rise in hemoglobin, restoration of iron stores with no serious adverse reaction. The intravenous iron sucrose therapy can replace blood transfusion in antenatal & postpartum women with moderate iron deficiency anaemia.